In-Q-Tel invests in Infobionics

The company has patented a method to organize, store, and search structured and unstructured data and discover previously unknown patterns.

Infobionics, a company that has patented a method to organize, store, and search structured and unstructured data and discover previously unknown patterns, said it has received an investment from In-Q-Tel, the CIA-backed venture capital firm.

Infobionics said its Cellular Database Management System provides agility and flexibility for query-intensive applications and helps perform quick and easy data analysis. Carl Bonta, the company’s president and chief operating officer, said the technology allows users to search for unusual, unforeseen patterns and identify what's missing.

Scott Yancey, president and chief executive officer of In-Q-Tel, said the technology has the potential to radically enhance data management applications across a range of industries.

In-Q-Tel continues to seek innovative technologies that address some of the most difficult challenges for commercial enterprises and the intelligence community, Yancey added. He said Infobionics’ proprietary technology offers great promise for leading-edge applications for customers in both markets.

Infobionics did not disclose the value of the investment.